Abstract
Since the introduction of clotting factor concentrates over 50 years ago the life expectancy of patients with hemophilia (PWH) has increased to over 70 years. Consequently, diseases of the ageing population, including coronary artery disease, are increasingly being encountered. These patients present a unique therapeutic problem due to their greatly increased bleeding risk. Randomized controlled studies specific to PWH are lacking, emphasizing the need for case series. We present three cases of acute coronary syndrome in PWH who underwent urgent percutaneous coronary intervention at our institution, and summarize the available literature on the topic. We describe their management and outcome and provide points to consider when treating these complex patients.
Similar content being viewed by others
References
Mejia-Carvajal C, Czapek EE, Valentino LA (2006) Life expectancy in hemophilia outcome. J Thromb Haemost 4(3):361–368
Darby SC, Kan SW, Spooner RJ, Giagrande PL, Hill FG, Hay CR, Lee CA, Ludlam CA, Williams M (2007) Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 110(3):815–825
Plug I, Van Der Bom JG, Peters M, Mauser-Bunscoten EP, De Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR (2006) Mortality and cases of death in patients with hemophilia, 1992–2001: a prospective cohort study. J Thromb Haemost 4(3):510–516
Franchini M, Tagliaferri A, Mannucci PM (2007) The management of hemophilia in elderly patients. Clin Interv Aging 2(3):261–268
Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B (2006) Myocardial infarction and other arterial occlusions in hemophilia A patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 116(2):120–125
Alsolaiman MM, Chang K, Arjoman H, Oza R, Costacurta G (2000) Acute left anterior descending artery occlusion in a hemophiliac A patient during recombinant factor VIII infusion: treatment with coronary angioplasty. Catheter Cardiovasc Interv 50(4):468–472
Wright RS, Anderson JL, Adams CD, Bridges CR, DE Casey Jr, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, DE Casey Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Theroux P, Wenger NK, Zidar JP, American college of cardiology foundation/American heart association task force on practice guidelines (2011) 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 57(19):e215–e367
Task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS), European association for percutaneous cardiovascular interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555
Vogel B, Hahne S, Kozanli I, Kalla K, Jarai R, Freynhofer M, Smetana P, Nurnberg M, Geppert A, Unger G, Huber K (2011) Influence of updated guidelines of short- and long-term mortality in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). Int J Cardiol. doi:10.1016/j.ijcard.2011.02.073
Furie B, Furie BC (1998) The molecular basis of blood coagulation. Cell 53:505–518
Furie B, Furie BC (1992) Molecular and cell biology of blood coagulation. N Engl J Med 326(12):800–806
White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, Factor VIII and factor IX subcommittee (2001) Definitions in hemophilia, recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost 85:560
Hoenig MR, Aroney CN, Scott IA (2010) Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane Database Syst Rev (3):CD004815
Segev A, Strauss BH, Tan M, Constance C, Langer A, Goodman SG, Canadian acute coronary syndromes registries investigators (2005) Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian acute coronary syndrome registries. Am Heart J 150(4):690–694
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114(8):774–782
Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP (2007) Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 7(4):225–233
Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, Berry B, Hilton JD (2008) Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L. study (mortality benefit of reduced transfusion after percutaneous coronary intervention via the arm or leg). Heart 94:1019–1025
Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Acute catheterization and urgent intervention triage strategy (ACUITY) trial investigators (2007) Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Lancet 369(9565):907–919
Montalescot G, Ongen Z, Guindy R, Sousa A, Lu SZ, Pahlajani D, Pellois A, Vicaut E, RIVIERA investigators (2007) Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study. Int J Cardiol 129:379–387
Schutgens RE, Tuinenburg A, Roosendaal G, Guyomi SH, Mauser-Bunschoten EP (2009) Treatment if ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia 15(4):952–958
Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR, RIVAL trial group (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomized, parallel group, multicentre trial. Lancet 377(9775):1409–1420
Virtanen R, Kauppila M, Itala M (2004) Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin. Thromb Haemost 92(5):1154–1156
Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, Pedrazzini G, Moccetti T, Wenaweser P, Togni M, Tuller D, Zbinden R, Seiler C, Mehilli J, Kastrati A, Meier B, Hess OM (2005) Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation 111(20):2617–2622
Leone AM, Sgueglia GA, Porto I, Niccoli G, Burzotta F, Trani C, De Caterina AR, Buffon A, Mazzari MA, Mongiardo R, Rebuzzi AG, Crea F (2010) The heart study: a real-world experience using the CID chrono carbostent in primary and rescue PCI. J Cardiovasc Med (Hagerstown). doi:10.2459/JCM.0b013e32834102d8
Klomp M, Beijk MA, Damman P, Woudstra P, Koch KT, Tijssen JG, de Winter RJ (2011) Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent. J Interv Cardiol 24(5):442–449
Petrillo G, Cirillo P, Leosco D, Maresca F, Piscione F, Chiariello M (2011) Percutaneous coronary intervention in a patient with acute non-ST-elevation myocardial infarction and haemophilia A: a ‘genous’ experience. Haemophilia 17:e239–e247
Krolick MA (2005) Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 11(4):415–417
Valgimigli M, Campo G, Monti M, Vranckx P, Percoco G, Tumscitz C, Castriota F, Colombo F, Tebaldi M, Fucà G, Kubbajeh M, Cangiano E, Minarelli M, Scalone A, Cavazza C, Frangione A, Borghesi M, Marchesini J, Parrinello G, Ferrari R, Prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia study (PRODIGY) investigators (2012) Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 125(16):2015–2026
Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wöhrle J (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59(15):1377–1382
Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, Guneri S, Gurfinkel E, Harrington R, Hochman JS, Kleiman NS, Leon MB, Lopez-Sendon JL, Pepine CJ, Ruzyllo W, Steinhubl SR, Teirstein PS, Toro-Figueroa L, White H, SYNERGY trial investigators (2004) Enoxaparin vs unfractionated heparin in high risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY trial. JAMA 292(1):45–54
Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332(20):1330–1335
Mamas MA, Ratib K, Routledge H, Fath-Ordoubadi F, Neyses L, Louvard Y, Fraser DG, Nolan J (2012) Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart 98(4):303–311
Yan BP, Ajani AE, Clark DJ, Duffy SJ, Andrianopoulos N, Brennan AL, Loane P, Reid CM (2011) Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne interventional group registry. Med J Aust 195(3):122–127
Hemophilia of Georgia, U.S.A.(2012) Protocols for the treatment of haemophilia and von Willebrand disease. http://www.hog.org
Forman MB, Kopelman HA, Gleaton JH, Janco RL, Perry JM (1986) Percutaneous transluminal angioplasty in hemophilia. Am Heart J 111(1):169–172
Helft G, Metzger JP, Samama MM, Rothschild C, Batisse JP, Vacheron A (1997) Coronary stenting in a hemophiliac patient. Thromb Haemost 77(5):1044–1045
Peerlinck K, Vermylen J (1999) Acute myocardial infarction following administration of recombinant activated factor VII (novo seven) in a patient the haemophilia A and inhibitor. Thromb Haemost 82(6):1775–1776
MacKinlay N, Taper J, Renisson F, Rickard K (2000) Cardiac surgery and catheterization in patients with haemophilia. Haemophilia 6(2):84–88
Au WY, Jim MH, Lam CC (2002) Unusual case of coronary artery disease in a patient with severe hemophilia B. Am J Hematol 69(2):152–153
Bovenzi F, De Luca L, Signore N, Fusco F, De Luca I (2003) Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 4(10):728–730
Arora UK, Dhir M, Cintron G, Strom JA (2004) Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol 16(6):330–332
Kerkhoffs JL, Atsma DE, Oemrawsingh PV, Eikenbloom J, Van der Meer FJM (2004) Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild haemophilia A. Thromb Haemost 92(2):425–426
Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A (2007) Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia 13(6):763–765
Smolka G, Kulach A, Dabek J, Szulc A, Gasior Z (2007) Percutaneous coronary intervention with stent implantation in haemophiliac A patient with unstable angina. Haemophilia 13(4):428–431
Quintero D, Biria M, Meyers DG (2008) Percutaneous coronary intervention in a patient with acute ST-elevation myocardial infarction and hemophilia A. J Invasive Cardiol 20(5):240–241
Pesaro AE, Gaz MV, Karbstein R, Perin M, Serrano CV, Damico E (2009) Coronary artery bypass surgery, angioplasty and long term anti-platelet treatment in a type B hemophilia patient. Clinics (Sao Paulo) 64(8):822–823
Kim DK, Kim DI, Kim MS, Lee EJ, Kim YB, Cho HJ, Han YC, Kim U, Seol SH, Yang TH, Kim DK, Kim DS (2010) Successful percutaneous coronary intervention for acute coronary syndrome in a patient with severe hemophilia A. Korean Circ J 40:527–529
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fefer, P., Gannot, S., Lubetsky, A. et al. Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management. J Thromb Thrombolysis 35, 271–278 (2013). https://doi.org/10.1007/s11239-012-0802-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-012-0802-y